Clinical Trials Logo

Clinical Trial Summary

Background Retinal vascular disorders, such as diabetic retinopathy, hypertensive retinopathy, retinal hemorrhage, and retinal vein occlusion are significant causes of vision impairment and blindness worldwide. Diabetic retinopathy (DR) is the most common retinal vascular disorder and is the leading cause of vision loss among patients aged 25 to 74 years. Aim to compare formulated Posterior Subtenon Triamcinolone acetonide (PSTA) injection versus Posterior Subtenon Triamcinolone acetonide alone versus suprachoroidal triamcinolone in the management of diabetic macular edema.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05464953
Study type Interventional
Source Al-Azhar University
Contact
Status Completed
Phase N/A
Start date January 20, 2020
Completion date April 30, 2022